Adherence

Adherence
 
Overview

EMeRGe is a partner in the European Innovation Partnership (EIP) on Active and Health Ageing Action Group A1 on Prescription and Adherence to medical plans. The EIP on AHA is an initiative launched by the European Commission to foster innovation and digital transformation in the field of active and healthy ageing. The main objective of the Group is to improve the quality of life and health outcomes of older people living with chronic conditions in at least 30 EU regions. Its action is based on a holistic approach, including enhanced self-care, personalized care, better treatment and increased adherence to safe and effective care plans. 

Link to this website


Medication adherence is the process by which patients consume their medications as prescribed by healthcare providers consisting of three distinct, yet inter-related phases; initiation, implementation and discontinuation.
Initiation refers to a patient fulfilling their prescription for a new medication and taking the medication as prescribed.
Implementation adherence represents the degree to which the patient’s actual dosing agrees with the prescribed regimen, from the first refill until the final dose.
Discontinuation occurs when the patient ceases to take the medication, regardless of whether this action was clinically indicated or not.[1] Medication non-adherence may occur at any phase.

Continue Reading

Prevalence of Adherence

The prevalence of medication non-adherence can vary depending on the type of medication(s) under review, the condition(s) for which the medication(s) is/are being used to treat and the population under study.
When regards to the type of medication, important factors to consider are the mode of delivery (tablets, capsules, inhalers) and the complexity of the dosing regimen (once daily vs multiple times per day). Medications with less complex regimens (one pill once daily, no interaction with food/other medications) tend to result in higher adherence than medications with more frequent dosing.[4]

 learn more

Predictors of Adherence

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

 learn more

Adherence & Health Outcomes

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

 learn more

Overview

Please read the below information on medication adherence and follow the links to relevant papers.

What is Medication Adherence?

Medication adherence is the process by which patients consume their medications as prescribed by healthcare providers consisting of three distinct, yet inter-related phases; initiation, implementation and discontinuation.

Initiation refers to a patient fulfilling their prescription for a new medication and taking the medication as prescribed. Implementation adherence represents the degree to which the patient’s actual dosing agrees with the prescribed regimen, from the first refill until the final dose.
Discontinuation occurs when the patient ceases to take the medication, regardless of whether this action was clinically indicated or not.[1]

Medication non-adherence may occur at any phase.

What constitutes non-adherence?

However, there is debate over what level of suboptimal medication adherence constitutes non-adherence. The most commonly used threshold is 80%, but this may vary according to the condition/medication under study. For instance, in conditions such as human immunodeficiency virus (HIV), adherence levels greater than 95% are required. Recent adherence studies have used a method developed in another field, group based trajectory modelling, to assign people into discrete adherence groups based on their longitudinal adherence data.[2]

Several Methods Used

There are several methods used to estimate medication adherence, with each having their respective pros and cons[2];

i. Self-report questionnaires; convenient, easy to administer and some have shown reliability and validity against other measures of adherence. However, may be subject to recall bias, measures adherence at one point in time (cross-sectional) and doesn’t provide granular information (number of medications, type of medications etc.) on medication non-adherence.[3]
ii. Pharmacy-refill claims; objective, provides information on the type of medications involved and adherence can be measured longitudinally. However, it is an indirect method as it assumes that all medication dispensed is consumed and, as with all data collected in administrative databases, may be subject to coding errors.
iii. Electronic monitoring devices (MEMs); accurate method, can track patient’s adherence longitudinally and can be indicative of intentional and non-intentional non-adherence (inhalers). However, it is an expensive method and is primarily used in clinical settings.
iv. Pill counts; objective, quantitative and easy to perform. However, patients can easily throw out pills (i.e pill dumping).
v. Direct methods (directly observed therapy, serum measurements); objective measurements of adherence but most likely used in a small sample sizes within a clinical trial setting. In addition, serum measurement can be affected by variations in metabolism.


The most commonly used methods for measuring medication adherence in the research literature are self-report questionnaires and pharmacy refill claims.

Epidemiology of adherence

The prevalence of medication non-adherence can vary depending on the type of medication(s) under review, the condition(s) for which the medication(s) is/are being used to treat and the population under study.
When regards to the type of medication, important factors to consider are the mode of delivery (tablets, capsules, inhalers) and the complexity of the dosing regimen (once daily vs multiple times per day). Medications with less complex regimens (one pill once daily, no interaction with food/other medications) tend to result in higher adherence than medications with more frequent dosing.[4]

Medication adherence in chronic conditions may be affected by factors such as disease pathogenesis, illness representations (health beliefs) and the presence of co-existing illness or multimorbidity. It is estimated that over 50% of people with chronic disorders are poorly adherent to their medication [5] and this may vary when looking at specific conditions. A pooled analysis of studies that analysed adherence to cardiovascular conditions found that 60% of patients were considered adherent (≥80%) to therapy.[6] Whereas for oral hypoglycaemic medications used in type 2 diabetes mellitus, the prevalence of adherence has been estimated at 68%.[7]


Medication non-adherence may be more of an issue in certain populations such as older people, due to the increased likelihood of polypharmacy and multimorbidity, as well as other socio-demographic variables. Experiencing a major clinical event such as a heart attack may make patients more adherent to secondary prevention medications in comparison to patients who are identified as at risk of a heart attack but have never experienced such an event (primary prevention). Patients who are newly started on a treatment regimen (new users) may have different adherence patterns to those who have been taking the medication(s) for a number of months/years (prevalent users).

Barriers to medication adherence

Barriers to adequate medication adherence can be separated into three unique, yet inter-related domains [2,8];

Patient factors
Patient’s understanding of their disease and the benefits/risks of the medication(s) can influence medication adherence. A poor understanding of disease pathogenesis and reduced confidence in the ability of the medication to improve symptoms or prognosis may increase the risk of medication non-adherence. Cognitive function, especially remembering to take the medication as prescribed, may be an important factor in elderly people. Health literacy, defined as ‘the degree to which individuals have the capacity to obtain, process and understand basic health information and services needed to make appropriate health decisions’[9], may act as a potential barrier to optimal medication adherence.

Health-system factors
The ease of access to the healthcare system is an important consideration. If patients find it difficult to attend clinic appointments, possibly due to cost or lack of resources, this may result in delays to prescription and dispensation of medications. Hospitalised patients may encounter a barrier to adequate medication adherence if their medication is not included in the hospital formulary. Similarly, if medications commenced in hospital are not reimbursed under community drug schemes, medication adherence may be adversely impacted. High medication costs may deter patients from refilling their prescriptions. Lack of integration of the healthcare system can also affect medication adherence.

Healthcare provider factors
The relationship between the prescriber/pharmacist and the patient can influence medication adherence. If there is a strong level of trust between the patient and the prescriber, the patient will place a high value on information about the medication from the prescriber. However, if the patient has a poor understanding of the disease and the benefit/risk ratio of treatment, medication adherence can be affected. Healthcare professionals, including nurses and pharmacists who can adequately explain correct use of the medication to the patient can aid adherence.

Adherence and Health Outcomes

The potential impact that medication adherence can have on surrogate outcomes such as blood pressure, for blood pressure lowering medications, and lipid levels, for cholesterol-has been established in the literature. However, when evaluating the potential clinical and economic burden of medication non-adherence, clinical endpoints such as heart attack and stroke need to be considered. The economic burden of medication non-adherence can be estimated by measuring the association between non-adherence and healthcare utilisation outcomes (hospitalisation, emergency department visits, general practitioner visits), quality of life and mortality. Our research focusses on the measurement of medication adherence and the association between medication non-adherence and health outcomes.
We have recently published a systematic review and meta-analysis of the association between medication non-adherence and health outcomes in those aged ≥50 years[10]. As people age, the number of co-morbidities they have to manage increases, resulting in polypharmacy. We found that that there was a significant association between medication non-adherence and hospitalisation (17% increased likelihood of hospitalisation in non-adherent people versus adherent people). Also, poor adherence to medications was associated with a 21% increased risk of death in comparison to good adherence. However, caution needs to be exercised when interpreting results of observational studies that quantify these relationships. Sometimes factors that can’t be measured, such as smoking, maintaining a healthy BMI and participation in health screening services, can bias the association between medication adherence and health outcomes, a phenomenon known as the ‘healthy adherer’ effect.
We noticed that there was a lack of studies that measured adherence to multiple medications across multiple conditions (multimorbidity). We feel this is an important area to address as multimorbidity is rising in the older population and this needs to be considered when determining adherence to chronic medications in this population. In addition, when considering the potential impact of medication non-adherence on health outcomes, such as health-related quality of life, consideration needs to be given to all chronic medications.

References

1. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology. 2012;73(5):691-705.
2. Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 2005;353(5):487-497.
3. Nguyen T-M-U, Caze AL, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. British Journal of Clinical Pharmacology. 2014;77(3):427-445.
4. Coleman CI, Limone B, Sobieraj DM, et al. Dosing frequency and medication adherence in chronic disease. Journal of Managed Care Pharmacy. 2012;18(7):527-539.
5. Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. Journal of Clinical Epidemiology. 2001;54(12, Supplement 1):S57-S60.
6. Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. European heart journal. 2013;34(38):2940-2948.
7. Iglay K, Cartier SE, Rosen VM, et al. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Current Medical Research and Opinion. 2015;31(7):1283-1296.
8. Gellad WF, Grenard J, McGlynn EA. A review of barriers to medication adherence. 2009.
9. Ratzan S, Parker R, Selden C, Zorn M. National library of medicine current bibliographies in medicine: health literacy. Bethesda, MD: National Institutes of Health, US Department of Health and Human Services2000.
10. Walsh CA, Cahir C, Tecklenborg S, Byrne C, Culbertson MA, Bennett KE. The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis. British Journal of Clinical Pharmacology. 2019;0(0).

Prevalence of Adherence

The prevalence of medication non-adherence can vary depending on the type of medication(s) under review, the condition(s) for which the medication(s) is/are being used to treat and the population under study.  When regards to the type of medication, important factors to consider are the mode of delivery (tablets, capsules, inhalers) and the complexity of the dosing regimen (once daily vs multiple times per day). Medications with less complex regimens (one pill once daily, no interaction with food/other medications) tend to result in higher adherence than medications with more frequent dosing.[4]

Medication adherence in chronic conditions may be affected by factors such as disease pathogenesis, illness representations (health beliefs) and the presence of co-existing illness or multimorbidity. It is estimated that over 50% of people with chronic disorders are poorly adherent to their medication [5] and this may vary when looking at specific conditions. A pooled analysis of studies that analysed adherence to cardiovascular conditions found that 60% of patients were considered adherent (≥80%) to therapy.[6] Whereas for oral hypoglycaemic medications used in type 2 diabetes mellitus, the prevalence of adherence has been estimated at 68%.[7]

Medication non-adherence may be more of an issue in certain populations such as older people, due to the increased likelihood of polypharmacy and multimorbidity, as well as other socio-demographic variables. Experiencing a major clinical event such as a heart attack may make patients more adherent to secondary prevention medications in comparison to patients who are identified as at risk of a heart attack but have never experienced such an event (primary prevention). Patients who are newly started on a treatment regimen (new users) may have different adherence patterns to those who have been taking the medication(s) for a number of months/years (prevalent users).

Research Papers

Predictors of Adherence

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Research Papers

Adherence & Health Outcomes

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Research Papers